MENU
SKYE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Skye Bioscience (SKYE) Ownership - Who owns Skye Bioscience?
Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
111.56M
P/E Ratio
3.57
Total Cash
48.59M
Projected Growth
N/A
Total Debt
367.54K
Revenue
N/A
Risk (Beta)
4.35
Dividend Yield
N/A
Total Cash/Share
1.57
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
SKYE
Capitalization
112M
P/E Ratio
3.57
Risk (Beta)
4.35
Dividend Yield
N/A
Total Cash
48.6M
Total Cash/Share
1.57
Total Debt
368K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
43.7M
P/B Ratio
2.55
Cash Flow
N/A
Earnings
-1.06
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
31K
Current Ratio
6.09
Current Revenue Per Employee
23699.00
Dividends Per Share - Security
N/A
EBITDA
-41.68M
Float
N/A
Float - Current
N/A
Gross Income Margin
72.69
Revenue To Assets
-60.78
Shares Held By Institutions
82.4M
Shares Outstanding - Current
31M
Total Liabilities
8.48M
Total Volume MTD
N/A
Value
N/A
Gain YTD
27.208
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information